Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Ethylamine | HCID 6341 | — |
| Reactant | Sodium Hydroxide | HCID 14798 | — |
| Reactant | 2-({2-{[1-(n,n-Dimethylglycyl)-5-(methyloxy)-2,3-dihydro-1h-indol-6-yl]amino}-7-[(4-methylphenyl)sulfonyl]-7h-pyrrolo[2,3-d]pyrimidin-4-yl}amino)-n-ethyl-4,6-difluorobenzamide | HCID 67316329 | — |
| Reactant | 5-{[1-(N,N-dimethylglycyl)-5-(methyloxy)-2,3-dihydro-1H-indol-6-yl]amino}-8,10-difluoro-3-[(4-methylphenyl)sulfonyl]pyrrolo[2',3':4,5]pyrimido[6,1-b]quinazolin-7(3H)-one | HCID 67316666 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Solvent | Ethyl Acetate | HCID 8857 | — |
| Solvent | 1,4-Dioxane | HCID 31275 | — |
| Product | HCID 178464913 | HCID 178464913 | — |
Reaction Steps
To a solution of 5-{[1-(N,N-dimethylglycyl)-5-(methyloxy)-2,3-dihydro-1H-indol-6-yl]amino}-8,10-difluoro-3-[(4-methylphenyl)sulfonyl]pyrrolo[2′,3′:4,5]pyrimido[6,1-b]quinazolin-7(3H)-one (300 mg, 0.445 mmol) in THF (5 mL) was added ethyl amine as a 2M solution in THF (1.11 mL, 2.22 mmol). The resulting mixture was let stir at rt for 3 h at which time it was diluted with ethyl acetate and washed with a saturated sodium bicarbonate solution, water and a saturated brine solution. Organics were dried over sodium sulfate and solvents removed under reduced pressure to afford a yellow solid, containing 2-({2-{[1-(N,N-dimethylglycyl)-5-(methyloxy)-2,3-dihydro-1H-indol-6-yl]amino}-7-[(4-methylphenyl)sulfonyl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}amino)-N-ethyl-4,6-difluorobenzamide. This material was dissolved in 1,4-dioxane (5 mL) and transferred to a 20 ml microwave vessel. A solution of 2M NaOH (5 ml) was added and reaction heated in microwave at 120° C. for 8 minutes. Resulting brown solution was diluted with ethyl acetate and washed with a saturated sodium bicarbonate solution, water and a saturated brine solution. Organics were dried over sodium sulfate and solvents removed under reduced pressure to afford a yellow solid which was purified via chromatography on SiO2 to afford 2-[(2-{[1-(N,N-dimethylglycyl)-5-(methyloxy)-2,3-dihydro-1H-indol-6-yl]amino}-1H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-N-ethyl-4,6-difluorobenzamide (60 mg, 0.101 mmol) as an off-white solid. 1H NMR (400 MHz, DMSO-d6) δ ppm 1.14 (t, J=7.14 Hz, 3 H) 2.18-2.31 (m, 6 H) 3.06-3.19 (m, 4H) 3.34 (dq, J=6.87, 6.65 Hz, 2 H) 3.78 (s, 3 H) 4.09-4.24 (m, 2 H) 6.25 (br. s., 1 H) 6.75-6.89 (m, 1 H) 6.93-7.03 (m, 2 H) 7.62-7.75 (m, 1 H) 8.39-8.49 (m, 1 H) 8.55 (br. s., 2 H) 10.55 (s, 1H) 11.26 (dd, J=2.56, 1.10 Hz, 1 H) (ESIMS (M+H)+=565)
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07981903B2 |
|---|
| Source dataset | uspto-grants-2011_07 |
|---|
| ORD ID | ord-5deb3479d3214a43be1c38a0fe6051f0 |
|---|
| Source note | uspto-grants-2011_07 |
|---|